Wednesday, April 18, 2007

Story last updated at 12:05 PM on Wednesday, April 18, 2007

Institute asks for people to test drug

The Saint Luke's Brain and Stroke Institute is seeking patients for continued clinical trials of a new multiple sclerosis medication that has shown promise in reducing relapses in people with MS. The drug, known as FTY720, is in its third phase of development and testing, which seeks to confirm data demonstrated in the second phase of testing. Call 1-866-788-3930.
http://www.examiner.net/stories/041807/new_041807026.shtml